by Pharmaceutical glass tubing is extensively used for the production of pharmaceutical packaging including vials, cartridges, ampoules and syringes. Pharmaceutical glass tubing offers properties like corrosion resistance, chemical compatibility, clarity and low levels of particulates which makes them suitable for pharmaceutical applications. The global pharmaceutical glass tubing market is driven by the growing demand for oral solid dosage formulations which requires glass containers for packaging. Pharmaceutical glass tubing helps ensure safety, purity and effectiveness of drugs inside the packaging.
The global Pharmaceutical Glass Tubing Market is estimated to be valued at US$ 8.3 Bn in 2023 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023-2030, as highlighted in a new report published by CoherentMI.
Market Key Trends:
One of the key trends in the pharmaceutical glass tubing market is the growing demand for parenteral drugs which require glass containers for packaging and delivery. As per estimates, over 60% of new drugs in the development pipeline are administered via injectables which will drive the demand for pharmaceutical glass tubing. Moreover, increasing investment in specialty glass by manufacturers is resulting in development of glass tubing with enhanced properties like uniform wall thickness, smooth surface and defect-free finish. This is enabling their use in more complex drug delivery systems. Growing focus on personalized medicine is also propelling the demand for pre-filled syringes and vials to maintain drug stability. The pharmaceutical glass tubing market players are hence focusing on developing tubing suitable for advanced applications.
Porter’s Analysis:
Threat of new entrants: The pharmaceutical glass tubing industry requires significant capital investments in specialized manufacturing equipment. Strict regulations from authorities also pose barriers for new firms.
Bargaining power of buyers: Buyers have higher bargaining power due to the availability of substitute products and commoditized nature of glass tubing. However, stringent quality standards and certifications in pharmaceuticals limit alternatives.
Bargaining power of suppliers: Key raw materials like borosilicate glass face limited supply sources globally. This allows larger suppliers to exert pressure on prices.
Threat of new substitutes: Alternatives like plastic are gaining ground for general packaging, but glass remains crucial for applications requiring high chemical resistance and heat processing capabilities.
Competitive rivalry: The market is highly competitive with large manufacturers competing on pricing, quality, and reliability of supply. Short product lifecycles increase pressure.
Global Pharmaceutical Glass Tubing Market Segmentation:
- By Product Type
- Vials
- Ampoules
- Cartridges
- Syringes
- Bottles
- Others (Tubes, Rods, Stoppers etc.)
- By End User
- Pharmaceutical
- Biotechnology
- Diagnostics
- Chemical
- Others (Research, Forensics etc.)
- By Distribution Channel
- Direct Sales
- Distributors
- Online
- Others
- By Manufacturing Process
- Tubing
- Molding
- Extrusion
- Others
Key Takeaways:
The global Pharmaceutical Glass Tubing Market Size is expected to witness high growth over the forecast period. The global Pharmaceutical Glass Tubing Market is estimated to be valued at US$ 8.3 Bn in 2023 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023-2030.
Regional Analysis: Asia Pacific has emerged as the leading producer and consumer of pharmaceutical glass tubing globally. China, India, Japan and South Korea account for over half of the total market share due to availability of raw materials, skilled labor and growing pharmaceutical industries in these countries.
Key Players: Key players operating in the pharmaceutical glass tubing market are Schott AG, Nipro Pharma Corporation, Corning Incorporated, NEG Glass, Shandong Pharmaceutical Glass Co., Ltd., Borosil Glass Works Ltd., Thermo Fisher Scientific, Richland Glass, Haldyn Glass Ltd., Duran Group GmbH, Epax Systems, Linuo Group Glass Products Co., Ltd., JSG Pharma, Fushan Technology, NAFEMS, Saverglass Group, Division of Berlin Packaging. Schott remains the largest player while Nipro, Corning and NEG have significant market shares.
*Note:
1.Source: CoherentMI, Public sources, Desk research
2.We have leveraged AI tools to mine information and compile it
